Imbruvica 140 mg
Price range: $6,300.00 through $17,550.00
Description
Imbruvica (ibrutinib) is a medication primarily used in the treatment of certain types of blood cancers, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma (MCL), Waldenström’s macroglobulinemia, and marginal zone lymphoma.
It belongs to a class of drugs known as Bruton’s tyrosine kinase (BTK) inhibitors, which work by blocking the activity of BTK, a protein involved in the growth and survival of cancer cells.
| Active Ingredient (Generic Name): | Imbruvica (ibrutinib) |
| Manufacturer: | Janssen Pharmaceuticals, India |
| Packaging: | 90 capsules in 1 bottle |
| Strength: | 140 MG |
| Delivery Time: | 6 To 15 days |
| SKU: | Imbruvica 140 mg |
Additional information
| Quantity Value | 90 Tablet/s, 180 Tablet/s, 270 Tablet/s |
|---|
Be the first to review “Imbruvica 140 mg”
You must be logged in to post a review.
Related products
-
Afatinib 20 mg
Price range: $98.00 through $278.00 Select options This product has multiple variants. The options may be chosen on the product page -
Afatinib Dimaleate 20 mg
Price range: $2,100.00 through $5,880.00 Select options This product has multiple variants. The options may be chosen on the product page -
Afatinib Dimaleate 50 mg
Price range: $2,268.00 through $6,468.00 Select options This product has multiple variants. The options may be chosen on the product page -
Crizotinib 250 mg
Price range: $4,140.00 through $11,700.00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.